1
|
Caderillo-Ruiz G, Diaz DC, López-Basave HN, Herrera M, Ruiz Garcia E, Melchor J, Trejo G, Aguilar JL, Herrera Gomez A, Meneses-Garcia A. Clinical outcome in patients who did not accept complementary surgery after neoadjuvant chemoradiotherapy (QT-RT) in locally advanced rectal cancer (LARC). J Clin Oncol 2016. [DOI: 10.1200/jco.2016.34.15_suppl.e15144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
2
|
Diaz DC, Caderillo-Ruiz G, Herrera M, Ruiz Garcia EB, Castro MF, López-Basave HN, Sarmiento IV, Padilla A, Aguilar JL, Herrera Gomez A. Blood neutrophil-lymphocyte ratio at diagnosis to predict treatment response in gastric cancer. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e15005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
3
|
Sobrevilla-Moreno N, Alvarez MA, Aguilar JL, Espinosa-Fernandez R, Martinez-Cedillo J, Miranda-Ponce Y, Escalona-Ledesma A, Jimenez M, Herrera Gomez A. Observation for clinical stage (CS) IS germ-cell tumors in patients treated at the National Cancer Institute in Mexico. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e15546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
4
|
Alvarez MA, Sobrevilla-Moreno N, Aguilar JL, Espinosa-Fernandez R, Martinez-Cedillo J, Miranda-Ponce Y, Escalona-Ledesma A, Jimenez M, Herrera Gomez A. Prognostic factors in patients with second and third line treatment for testicular germ-cell tumors (TGCT): analysis of patients treated at the National Institute of Cancer (INCan), Mexico. J Clin Oncol 2015. [DOI: 10.1200/jco.2015.33.15_suppl.e15548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
5
|
Basave HNL, Morales-Vasquez F, Monterrubio JCT, Gomez AH, Molina JMR, Esquivel GM, Lino-Silva LS. Primary gastric hemangioblastoma: report of a case. Rare Tumors 2015; 7:5679. [PMID: 25918611 PMCID: PMC4387357 DOI: 10.4081/rt.2015.5679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2014] [Revised: 11/25/2014] [Accepted: 11/28/2014] [Indexed: 11/22/2022] Open
Abstract
Capillary hemangioblastoma (CHB) is a benign, highly vascularized tumor that generally occurs in central nervous system either in the setting of von Hippel-Lindau (VHL) disease or, more often, as a solitary sporadic lesion that is increasingly recognized in extraneural sites. We present the case of a 18 year-old man with abdominal pain, nausea and hematemesis, the endoscopy showed polypoid tumor bleeding of 5 cm in gastric antrum. The patients had not signs of VHL disease and was subjected to subtotal gastrectomy and referred to our institution. To our knowledge this is the first reported case of CHB occurring in stomach.
Collapse
Affiliation(s)
- Horacio N López Basave
- Surgical Oncology, Gastroenterology Division, Instituto Nacional de Cancerología , México City, México
| | | | | | - Angel Herrera Gomez
- Surgical Oncology, Gastroenterology Division, Instituto Nacional de Cancerología , México City, México
| | - Juan Manuel Ruiz Molina
- Surgical Oncology, Gastroenterology Division, Instituto Nacional de Cancerología , México City, México
| | - Gonzalo Montalvo Esquivel
- Surgical Oncology, Gastroenterology Division, Instituto Nacional de Cancerología , México City, México
| | | |
Collapse
|
6
|
Aguilar JL, Martinez IA, Villarreal-Garza CM, Lara GA, Medina FL, Alvarado Miranda A, De La Garza JG, Mohar A, Meneses A, Herrera Gomez A, Olvera-Caraza D, Granados-Garcia M, Arrieta O. Impact of obesity and overweight in the prognosis of women diagnosed with non metastatic breast cancer in a Mexican cohort. J Clin Oncol 2012. [DOI: 10.1200/jco.2012.30.15_suppl.1607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
1607 Background: Mexico positions right up at the top with U.S. in worldwide rankings of the most obese countries. In addition, breast cancer (BrCa) is the main type of cancer among women in this country. Studies have shown inconsistent results regarding obesity as a prognostic factor for worse outcome. Methods: Our aim is to identify if overweight and obesity confer poor prognosis in non-metastasic BrCa patients (pts). We identified 1799 Hispanic women with newly diagnosed BrCa who attended the National Cancer Institute in Mexico from 2004-2008 and compared clinical and pathological features and overall survival (OS) between pts with a body mass index (BMI) > or ≤ than 25. Results: The median age at diagnosis was 51 years. A BMI>25 was found in 71% of pts. Postmenopausal women comprised 52%, and had a greater proportion of cases with a BMI>25 than premenopausal pts (75% vs. 67%, p<0.0001). Pts with BMI>25 presented with more advanced TNM stages and nodal involvement than their counterparts (73% vs. 67%, p=0.005 and 76% vs. 71%, p=0.017; respectively). Overall prevalence of hormone-receptor (HR), triple-negative (TN) and HER2 positive disease was 62%, 23%, and 27%, respectively. Differences according to receptor status between pre and postmenopausal pts and BMI are shown in table. There was no difference in disease-free survival and OS according to overweight and obesity in the overall population, but when menopausal status was considered, premenopausal pts with BMI>25 had a worse OS compared to pts with BMI<25 (HR 1.6, p=0.037). This difference was not seen in the postmenopausal group. Conclusions: Obesity may influence BrCa outcomes via several hormonal and inflammatory mechanisms. In this study, overweight and obesity confer a poor prognosis in premenopausal patients, possibly related to excess estrogen availability and higher prevalence of TN BrCa. Therefore, overweight and obesity deserve additional attention to assess possible causal relationships that potentially could be modified to improve outcomes in premenopausal patients. [Table: see text]
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | - Oscar Arrieta
- Instituto Nacional de Cancerologia, Mexico City, Mexico
| |
Collapse
|